sansert has been researched along with Migraine Disorders in 2 studies
1-methyllysergic acid butanolamide: RN given refers to parent cpd(8beta)-isomer
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DOMINGUEZ LAZARO, AR | 1 |
| SASTRE CASTILLO, A | 1 |
| PEREZ GUERRERO, J | 1 |
| CALLEJA CANELAS, JL | 1 |
| CROWTHER, DL | 1 |
2 other studies available for sansert and Migraine Disorders
| Article | Year |
|---|---|
[UML-491 (1-methyl-D-lysergic acid butanolamide) in the prevention and treatment of migraine and other types of headache].
Topics: Biomedical Research; Headache; Lysergic Acid; Lysergic Acid Diethylamide; Methysergide; Migraine Dis | 1962 |
THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.
Topics: Analgesics; Ergot Alkaloids; Facial Neuralgia; Humans; Lysergic Acid; Lysergic Acid Diethylamide; Me | 1964 |